Kai Thede
31Patents
4h-index
97Co-inventors
62Inventor score
Filing activity: May 14, 2005 → Sep 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10981932B2 | Macrocyclic indole derivatives | Chemistry; Metallurgy | 9 | Active |
| US8252817B2 | Dipyridyl-dihydropyrazolones and their use | Chemistry; Metallurgy | 7 | Active |
| US8524699B2 | Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US8653111B2 | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Chemistry; Metallurgy | 5 | Active |
| US11447504B2 | Macrocyclic chlorine substituted indole derivatives | Chemistry; Metallurgy | 3 | Active |
| US8609698B2 | Substituted dipyridyl-dihydropyrazolones and use thereof | Human Necessities | 3 | Active |
| US11492358B1 | Macrocyclic indole derivatives | Chemistry; Metallurgy | 3 | Active |
| US11286263B2 | Macrocyclic fluorine substituted indole derivatives | Chemistry; Metallurgy | 3 | Active |
| US11478451B1 | Macrocyclic chlorine substituted indole derivatives | Chemistry; Metallurgy | 3 | Active |
| US11401278B2 | Macrocyclic indole derivatives | Chemistry; Metallurgy | 3 | Active |
| US8389520B2 | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Chemistry; Metallurgy | 3 | Active |
| US11440923B2 | Substituted macrocyclic indole derivatives | Chemistry; Metallurgy | 3 | Active |
| US7569563B2 | Substituted quinolones II | Human Necessities | 2 | Active |
| US9000026B2 | Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy | Chemistry; Metallurgy | 2 | Active |
| US8399682B2 | Substituted (pyrazolylcarbonyl)imidazolidinones and their use | Chemistry; Metallurgy | 2 | Active |
| US12152041B2 | Macrocyclic fluorine substituted indole derivatives | Chemistry; Metallurgy | 1 | Active |
| US9085572B2 | 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases | Chemistry; Metallurgy | 1 | Active |
| US8324268B2 | Substituted furancarboxamides, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11891404B2 | Substituted macrocyclic indole derivatives | Chemistry; Metallurgy | 1 | Active |
| US9278925B2 | Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one | Human Necessities | 1 | Active |
| US8030347B2 | Cylopenta[b]benzofuran derivatives and the utilization thereof | Human Necessities | 1 | Active |
| US8546438B2 | Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof | Human Necessities | 0 | Active |
| US7867992B2 | Substituted quinolones | Chemistry; Metallurgy | 0 | Active |
| US8987261B2 | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Chemistry; Metallurgy | 0 | Active |
| US8575357B2 | Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.